Home > Focus Areas > Lipid Management Connect > Post
Multimorbidity and statin prescription for primary prevention of cardiovascular diseases: A cross-sectional study in general practice in France
Source : https://www.frontiersin.org/articles/10.3389/fmed.2022.1089050/full
BackgroundStatins are a first line, evidence-based yet underprescribed treatment for cardiovascular primary prevention.
Conclusion: Multimorbidity, in itself, does not seem to be a determinant factor for appropriate statin prescription. The latter appears to be determined by a patient’s type of multimorbidity, especially the presence or not of diabetes. Differentiating between diabetic and non-diabetic multimorbidity may be a pragmatic way for GPs to improve primary prevention in a patient-centered and shared decision-making approach.